×
Biodesix EBIT 2020-2024 | BDSX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biodesix ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Biodesix EBIT 2020-2024 | BDSX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biodesix ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$151.7B
Elevance Health (ELV)
$90.6B
Cencora (COR)
$47.6B
Natera (NTRA)
$23.1B
DiDi Global (DIDIY)
$22.8B
ICON (ICLR)
$16.2B
Avantor (AVTR)
$14.8B
Revvity (RVTY)
$14.5B
BioMerieux (BMXMF)
$14.3B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.9B
CochLear (CHEOY)
$12.8B
Medpace Holdings (MEDP)
$11.2B
Doximity (DOCS)
$10.9B
EUROFINS SCIENT (ERFSF)
$10B
HealthEquity (HQY)
$9.7B
Sonic Healthcare (SKHHY)
$8.5B
Charles River Laboratories (CRL)
$8.5B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$5.7B
BrightSpring Health Services (BTSG)
$3.9B
Sotera Health (SHC)
$3.9B
Organon (OGN)
$3.8B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.9B
PACS (PACS)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
Teladoc Health (TDOC)
$2.1B
Progyny (PGNY)
$1.9B